Has Angela Tyler received payments from drug or device companies?

Yes. Drug and device makers reported $1,860 in general payments to Angela Tyler across 88 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angela Tyler did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angela Tyler come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angela Tyler

Family · Odessa, TXNPI 1720625213

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $899 and has fallen 86.8% since, to $119 in 2025.

$1,860in general payments, 2019–2025

Across 88 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biodelivery Sciences International, Inc.$350
AbbVie$253
Biohaven Pharmaceutical Holding Company Ltd.$212
Arbor Pharmaceuticals, Inc.$136
Collegium Pharmaceutical, Inc.$126
Lundbeck LLC$123
plus $660 from 12 others

What the payments were for

Food & beverage$1,860100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biodelivery Sciences International, Inc.	29	$350
AbbVie	13	$253
Biohaven Pharmaceutical Holding Company Ltd.	8	$212
Arbor Pharmaceuticals, Inc.	6	$136
Collegium Pharmaceutical, Inc.	9	$126
Lundbeck LLC	1	$123
Takeda Pharmaceuticals U.S.A., Inc.	1	$114
Si-bone, Inc.	1	$110
Boston Scientific	2	$107
Scilex Pharmaceuticals Inc.	4	$65
Pfizer	3	$48
Novo Nordisk	2	$46
Baudax Bio Inc.	2	$39
Boehringer Ingelheim	2	$37
AstraZeneca	2	$35
Teva Pharmaceuticals USA, Inc.	1	$21
Lilly USA, LLC	1	$20
Kowa Pharmaceuticals America, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,860 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Odessa

David WeirDallas$959K
Robin BeachHouston$428K
April LopezMcAllen$417K
Sarah AguilarHouston$199K
Sie ThomasDallas$197K
Anna CastroSan Antonio$184K
Jill CampbellShenandoah$182K
Angela AchaPflugerville$174K
Susan BowlinIrving$164K
Stephanie RodriguezCorpus Christi$159K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →